Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

732 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Elevated serum levels of Wisteria floribunda agglutinin-positive human Mac-2 binding protein predict the development of hepatocellular carcinoma in hepatitis C patients.
Yamasaki K, Tateyama M, Abiru S, Komori A, Nagaoka S, Saeki A, Hashimoto S, Sasaki R, Bekki S, Kugiyama Y, Miyazoe Y, Kuno A, Korenaga M, Togayachi A, Ocho M, Mizokami M, Narimatsu H, Yatsuhashi H. Yamasaki K, et al. Among authors: nagaoka s. Hepatology. 2014 Nov;60(5):1563-70. doi: 10.1002/hep.27305. Epub 2014 Oct 2. Hepatology. 2014. PMID: 25042054 Free PMC article.
Cytokine gene polymorphisms in Japanese patients with hepatitis B virus infection--association between TGF-beta1 polymorphisms and hepatocellular carcinoma.
Migita K, Miyazoe S, Maeda Y, Daikoku M, Abiru S, Ueki T, Yano K, Nagaoka S, Matsumoto T, Nakao K, Hamasaki K, Yatsuhashi H, Ishibashi H, Eguchi K. Migita K, et al. Among authors: nagaoka s. J Hepatol. 2005 Apr;42(4):505-10. doi: 10.1016/j.jhep.2004.11.026. Epub 2004 Dec 10. J Hepatol. 2005. PMID: 15763337
Enhanced expression of type I interferon and toll-like receptor-3 in primary biliary cirrhosis.
Takii Y, Nakamura M, Ito M, Yokoyama T, Komori A, Shimizu-Yoshida Y, Nakao R, Kusumoto K, Nagaoka S, Yano K, Abiru S, Ueki T, Matsumoto T, Daikoku M, Taniguchi K, Fujioka H, Migita K, Yatsuhashi H, Nakashima M, Harada M, Ishibashi H. Takii Y, et al. Among authors: nagaoka s. Lab Invest. 2005 Jul;85(7):908-20. doi: 10.1038/labinvest.3700285. Lab Invest. 2005. PMID: 15856047 Free article.
Measurement of hepatitis B virus core-related antigen is valuable for identifying patients who are at low risk of lamivudine resistance.
Tanaka E, Matsumoto A, Suzuki F, Kobayashi M, Mizokami M, Tanaka Y, Okanoue T, Minami M, Chayama K, Imamura M, Yatsuhashi H, Nagaoka S, Yotsuyanagi H, Kawata S, Kimura T, Maki N, Iino S, Kiyosawa K; HBV Core-Related Antigen Study Group. Tanaka E, et al. Among authors: nagaoka s. Liver Int. 2006 Feb;26(1):90-6. doi: 10.1111/j.1478-3231.2005.01200.x. Liver Int. 2006. PMID: 16420514
Fenofibrate-induced liver injury.
Dohmen K, Wen CY, Nagaoka S, Yano K, Abiru S, Ueki T, Komori A, Daikoku M, Yatsuhashi H, Ishibashi H. Dohmen K, et al. Among authors: nagaoka s. World J Gastroenterol. 2005 Dec 28;11(48):7702-3. doi: 10.3748/wjg.v11.i48.7702. World J Gastroenterol. 2005. PMID: 16437706 Free PMC article. No abstract available.
Low serum level of hepatitis B core-related antigen indicates unlikely reactivation of hepatitis after cessation of lamivudine therapy.
Matsumoto A, Tanaka E, Minami M, Okanoue T, Yatsuhashi H, Nagaoka S, Suzuki F, Kobayashi M, Chayama K, Imamura M, Yotsuyanagi H, Nakaoka S, Maki N, Kawata S, Kumada H, Iino S, Kiyosawa K. Matsumoto A, et al. Among authors: nagaoka s. Hepatol Res. 2007 Aug;37(8):661-6. doi: 10.1111/j.1872-034X.2007.00094.x. Hepatol Res. 2007. PMID: 17584261
[Natural course and recommendation of therapy for HBV infection].
Yatsuhashi H, Nagaoka S, Abiru S. Yatsuhashi H, et al. Among authors: nagaoka s. Nihon Shokakibyo Gakkai Zasshi. 2007 Oct;104(10):1450-8. Nihon Shokakibyo Gakkai Zasshi. 2007. PMID: 17917392 Review. Japanese. No abstract available.
732 results